Pot-stock RotoGro scores first $1M from Miracle Valley
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Roto-Gro World Wide (Canada) Inc., a wholly owned subsidiary of Roto-Gro International Limited (ASX:RGI), has received the first $1 million of the $2.3 million order secured from Miracle Valley Medicinal Alternatives M.V.M.A. Ltd.
The privately owned Miracle Valley is currently building a 29,000 square foot state-of-the-art cultivation and manufacturing facility in British Columbia, Canada.
The receipt of this first payment triggers the production of RotoGro Hydroponic Garden Systems, which are needed to complete the buildout of Miracle Valley’s facility. This buildout is also the final stage for Miracle Valley to obtain its medicinal cannabis production license from Health Canada.
RotoGro and Miracle Valley have agreed that the first delivery of RotoGro Hydroponic Garden Systems will kick off at the end of this quarter, with subsequent deliveries being made on a room-by-room basis through the second half of 2018, as Miracle Valley advances its Health Canada license through Introductory Inspection (as cultivation begins) to a License to Sell.
Once the facility is completed, it will produce up to 12,000 lbs (5,400 kilograms) of legal cannabis per year, harnessing RGI’s leading-edge patented and patent-pending designs, which provide the lowest cost per gram and the highest yield per square foot in the industry. The facility will utilise cutting-edge growing, building and information technologies to produce industry-leading yields, as well as the highest quality cannabis.
RGI managing director, Michael Carli said: “We are very pleased with the collaborative working relationship we have with Miracle Valley as it commences build-out, delivery and installation of our patented RotoGro Hydroponic Garden Systems.
“The success of this order is driven by the early engagement of RotoGro working ‘hand in glove’ with our clients to ensure they receive the best support from concept to design and build-out to production. Our team continues to work diligently with RotoGro’s prospective clients across the lawful cannabis and perishable foods space to nurture our sales pipeline for future orders.”
It’s worth noting here that RGI is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
